POLYETHYLENE GLYCOL — all Canadian products
37 DINs
24 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is POLYETHYLENE GLYCOL, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02464136 | CLARILAX | PHARMASCIENCE INC | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 1 G | Approved | |
| 02324989 | CLEARLAX | PERRIGO INTERNATIONAL | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 100 % | Marketed | |
| 02450070 | COLAXOR | MANTRA PHARMA INC | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 100 % | Marketed | |
| 00677442 | COLYTE | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Powder For Solution | Nasogastric; Oral | POLYETHYLENE GLYCOL 3350 857.69 MG; SODIUM CHLORIDE 20.87 MG; POTASSIUM CHLORIDE 10.65 MG; SODIUM BICARBONATE 24.02 MG; SODIUM SULFATE 81.2 MG | Marketed | |
| 02460297 | COMFILAX | CELLCHEM PHARMACEUTICALS INC. | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 100 % | Marketed | |
| 02374137 | EMOLAX | JAMP PHARMA CORPORATION | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 100 % | Marketed | |
| 02492121 | EMOLAX 3350 | JAMP PHARMA CORPORATION | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 100 % | Approved | |
| 02473119 | HYDRALAX | JUNO OTC INC | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 17 G | Marketed | |
| 02406780 | JAMP-ELECTROPEG | JAMP PHARMA CORPORATION | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 236.0 G; SODIUM SULFATE 22.74 G; SODIUM BICARBONATE 6.74 G; SODIUM CHLORIDE 5.86 G; POTASSIUM CHLORIDE 2.97 G | Approved | |
| 02406799 | JAMP-ELECTROPEG WITH FLAVOUR PACKET | JAMP PHARMA CORPORATION | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 236.0 G; SODIUM SULFATE 22.74 G; SODIUM BICARBONATE 6.74 G; SODIUM CHLORIDE 5.86 G; POTASSIUM CHLORIDE 2.97 G | Approved | |
| 02368234 | JAMPLYTE | JAMP PHARMA CORPORATION | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 59.55 G; SODIUM SULFATE 5.74 G; SODIUM BICARBONATE 1.69 G; SODIUM CHLORIDE 1.46 G; POTASSIUM CHLORIDE 0.76 G | Approved | |
| 02378329 | JAMPLYTE | JAMP PHARMA CORPORATION | Powder | Oral | POLYETHYLENE GLYCOL 3350 238.2 G; SODIUM SULFATE 22.96 G; SODIUM BICARBONATE 6.76 G; SODIUM CHLORIDE 5.84 G; POTASSIUM CHLORIDE 3.04 G | Marketed | |
| 02317680 | LAX-A-DAY | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 100 % | Marketed | |
| 02453193 | LAX-A-DAY PHARMA | PHARMASCIENCE INC | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 100 % | Marketed | |
| 02548933 | LAXATIVE | PHARMASCIENCE INC | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 100 % | Marketed | |
| 02359499 | MOVIPREP | ARALEZ PHARMACEUTICALS CANADA INC | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 100 G; SODIUM SULFATE ANHYDROUS 7.5 G; SODIUM CHLORIDE 2.691 G; POTASSIUM CHLORIDE 1.015 G; ASCORBIC ACID 4.7 G; SODIUM ASCORBATE 5.9 G | Marketed | |
| 02358034 | PEG 3350 | MEDISCA PHARMACEUTIQUE INC | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 100 % | Marketed | |
| 02520796 | PEG 3350 | ANGITA PHARMA INC. | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 100 % | Marketed | |
| 02513390 | POLYETHYLENE GLYCOL 3350 | ANGITA PHARMA INC. | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 100 % | Approved | |
| 02518201 | RED EYE TRIPLE ACTION | KENVUE CANADA INC. | Drops | Ophthalmic | POLYETHYLENE GLYCOL 400 1 %; TETRAHYDROZOLINE HYDROCHLORIDE 0.05 % | Marketed | |
| 02518228 | RED EYE WORKPLACE | KENVUE CANADA INC. | Drops | Ophthalmic | POLYETHYLENE GLYCOL 400 1 %; TETRAHYDROZOLINE HYDROCHLORIDE 0.05 % | Marketed | |
| 02346672 | RELAXA | MEDEXUS PHARMACEUTICALS INC. | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 100 % | Marketed | |
| 02318164 | RESTORALAX | BAYER INC | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 100 % | Marketed | |
| 02520885 | RIVA-LAX | LABORATOIRE RIVA INC. | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 17 G | Approved | |
| 02230825 | ELECTROPEG SOLUTION | TECHNILAB PHARMA INC. | Powder | Oral | POLYETHYLENE GLYCOL 3350 238.8 G; SODIUM BICARBONATE 6.7 G; SODIUM CHLORIDE 5.8 G; SODIUM SULFATE 22.7 G; POTASSIUM CHLORIDE 3 G | Cancelled Post Market | |
| 02455617 | LAX-A-DAY MEN | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 100 % | Cancelled Post Market | |
| 02463970 | LAX-RELIEF | PHARMASCIENCE INC | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 100 % | Cancelled Pre Market | |
| 02391007 | LAXACLEAR | PERRIGO INTERNATIONAL | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 100 % | Cancelled Pre Market | |
| 02428989 | LUBRICANT EYE DROPS | ADVANCED VISION RESEARCH, INC. | Solution | Ophthalmic | POLYETHYLENE GLYCOL 400 0.4 %; PROPYLENE GLYCOL 0.3 % | Cancelled (Unreturned Annual) | |
| 02239569 | LYTEPREP | THERAPEX DIVISION DE E-Z-EM CANADA INC | Powder | Oral | POLYETHYLENE GLYCOL 3350 236 G; SODIUM SULFATE 22.74 G; SODIUM BICARBONATE 6.74 G; SODIUM CHLORIDE 5.86 G; POTASSIUM CHLORIDE 2.97 G | Cancelled Post Market | |
| 02328232 | PEGALAX | ARALEZ PHARMACEUTICALS CANADA INC | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 100 % | Cancelled Post Market | |
| 02550938 | PLENVU | BAUSCH HEALTH, CANADA INC. | Powder For Solution; Kit | Oral | POLYETHYLENE GLYCOL 3350 140 G; SODIUM ASCORBATE 48.11 G; SODIUM SULFATE ANHYDROUS 9 G; ASCORBIC ACID 7.54 G; SODIUM CHLORIDE 5.2 G; POTASSIUM CHLORIDE 2.2 G | Cancelled Pre Market | |
| 02330326 | POLYLAX | SEAFORD PHARMACEUTICALS INC | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 100 % | Cancelled Post Market | |
| 02147785 | PROLAX - PWS | RIVEX PHARMA INC. | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 14.75 G; SODIUM SULFATE 1.42 G; SODIUM BICARBONATE 420 MG; SODIUM CHLORIDE 370 MG; POTASSIUM CHLORIDE 190 MG | Cancelled Post Market | |
| 02415054 | PURELAX | PERRIGO INTERNATIONAL | Powder For Solution | Oral | POLYETHYLENE GLYCOL 3350 100 % | Cancelled Post Market | |
| 02248967 | SYSTANE LUBRICANT EYE DROPS | ALCON CANADA INC | Solution | Ophthalmic | POLYETHYLENE GLYCOL 400 0.4 %; PROPYLENE GLYCOL 0.3 % | Cancelled Post Market | |
| 02153610 | VISINE TRUE TEARS - LIQUID | PFIZER CANADA INC., CONSUMER HEALTHCARE DIVISION | Liquid | Ophthalmic | POLYETHYLENE GLYCOL 400 1 % | Cancelled Post Market |
Browse other molecules: